Quick Takeaways
- This page summarizes Athanasios Skarpelos's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 29 Jun 2022, 17:10.
Athanasios Skarpelos - 27 Jun 2022 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Role
- Director
- Signature
- /s/Athanasios Skarpelos
- Issuer symbol
- AVXL
- Transactions as of
- 27 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 29 Jun 2022, 17:10:20 UTC
- Previous filing
- 27 May 2022
- Next filing
- 04 Apr 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Athanasios Skarpelos filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 29 Jun 2022."
What Changed
- Previous filing in this sequence was filed on 27 May 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVXL | Stock Option (Right to Buy) | Award | $0 | +50,000 | $0.000000 | 50,000 | 27 Jun 2022 | Common Stock | 50,000 | $10.09 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.